Bill Text: NJ A3816 | 2018-2019 | Regular Session | Introduced


Bill Title: Requires DOH to license certain qualifying hospitals providing elective angioplasty services.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2018-04-05 - Introduced, Referred to Assembly Health and Senior Services Committee [A3816 Detail]

Download: New_Jersey-2018-A3816-Introduced.html

ASSEMBLY, No. 3816

STATE OF NEW JERSEY

218th LEGISLATURE

 

INTRODUCED APRIL 5, 2018

 


 

Sponsored by:

Assemblyman  HERB CONAWAY, JR.

District 7 (Burlington)

 

 

 

 

SYNOPSIS

     Requires DOH to license certain qualifying hospitals providing elective angioplasty services.

 

CURRENT VERSION OF TEXT

     As introduced.

  


An Act concerning the licensure of certain qualifying hospitals and supplementing Title 26 of the Revised Statutes.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    As used in this act:

     "Bona fide shared governance" means a financial, operational, and clinical overlap between a mentor hospital and its mentee hospital, both of which are part of the same health care network. An affiliation agreement between a mentor hospital and a mentee hospital shall not constitute shared governance unless the mentee hospital is a fully integrated part of the mentor hospital's system.

     "Mentee hospital" means an acute care hospital that:

     a.     is part of a health care network and does not perform on-site coronary artery bypass graft (CABG) surgical procedures but receives such surgical back-up from its mentor hospital;

     b.    has not been licensed by the Department of Health to participate in the Cardiovascular Patient Outcomes Research Team Elective Angioplasty Study (C-PORT-E) clinical trial or the New Jersey State Elective Angioplasty Demonstration Project; and

     c.     maintains bona fide shared governance with a mentor hospital.

     "Mentor hospital" means an acute care hospital located within New Jersey that:

     a.     is part of a health care network and holds an unconditional license to perform cardiac surgery issued by the Department of Health;

     b.    meets the minimum 350 open heart surgery operation per year requirement set forth in N.J.A.C. 8:43G-7.2;

     c.     reports quality data to the Department of Health; and

     d.    provides on-site coronary artery bypass graft surgical backup to its healthcare network hospitals, including its mentee hospital, over which it assumes primary, exclusive, and ultimate responsibility for the oversight of all clinical, programmatic, staffing, and volume requirements, as well as quality outcomes in the performance of elective percutaneous coronary intervention (PCI) by the mentee hospital.

 

     2.    A general hospital may apply to the Commissioner of Health for a license to provide elective angioplasty services in the State.  The commissioner shall issue a license to any hospital that, on the effective date of P.L.    , c.    (C.      ) (pending before the Legislature as this bill):

     a.     is not currently licensed as a cardiac surgery facility;

     b.    holds licensure to participate in the Atlantic C-PORT-E clinical trial as of the effective date of this act or is a mentee hospital that is licensed by the department as a primary percutaneous coronary intervention provider;

     c.     demonstrates the ability to perform a minimum of 200 elective angioplasty procedures per year, with each interventional cardiologist performing at least 75 elective angioplasty procedures per year;

     d.    establishes a transportation plan and protocol, which has been approved by the commissioner, for patients who require transportation to, and receipt at, a licensed cardiac surgery center in the event the patient experiences a cardiac emergency or procedure-related complications; and

     e.     meets such other requirements as the commissioner may establish by regulation.

 

     3.    The Commissioner of Health may adopt rules and regulations, in accordance with the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), as the commissioner deems necessary to effectuate the purposes of this act.

 

     4.    This act shall take effect immediately.

 

 

STATEMENT

 

     This bill requires the Commissioner of Health to issue a license to certain general hospitals to perform elective angioplasty procedures, which are procedures used to widen clogged arteries and help remove blockages, restoring blood flow and potentially reducing the risk of an adverse cardiac event. 

     Specifically, the bill requires the Commissioner of Health to license hospitals to provide elective angioplasty procedures, provided that the facility, as of the effective date of the bill:

·         is not a licensed cardiac surgery facility;

·         is currently participating in the Atlantic Cardiovascular Patient Outcomes Research Team Elective Angioplasty Study (C-PORT-E) clinical trial or is a "mentee hospital" as defined in the bill;

·         demonstrates the ability to perform a minimum of 200 elective angioplasty procedures per year, with each cardiologist performing at least 75 procedures per year;

·         establishes a transportation plan and protocol for patients experiencing a cardiac emergency or procedure-related complications to be transported to, and received at, a licensed cardiac surgery center; and

·         meets any other requirements established by the commissioner.

     The bill defines "mentee hospital" to mean an acute care hospital that is part of a health care network, does not perform on-site coronary artery bypass graft (CABG) procedures, was not licensed to participate in the C-PORT-E study or the New Jersey Elective Angioplasty Demonstration Project, and maintains bona fide shared governance with a "mentor hospital."  A "mentor hospital" is defined to mean an acute care hospital that holds an unrestricted license to perform cardiac surgery, performs at least 350 open heart surgical procedures per year, reports quality data to the Department of Health, and provides on-site CABG surgical backup to its network hospitals, over which it assumes primary, exclusive, and ultimate responsibility for the oversight of all clinical, programmatic, staffing, and volume requirements, as well as quality outcomes in the performance of elective percutaneous coronary interventions by the mentee hospital.  "Bona fide shared governance" means a fully-integrated financial, operational, and clinical overlap between a mentor and mentee hospital.

feedback